Stay updated on Selonsertib in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Selonsertib in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the Selonsertib in Diabetic Kidney Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows Revision: v3.6.4 in place of v3.6.3, indicating a minor update to the page's revision metadata. This update does not affect the study information or history content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study history now includes a new revision entry, updating the version from v3.6.2 to v3.6.3, reflecting a recent platform or documentation update on the history page. This change pertains to site versioning rather than trial data or participant information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of v3.6.0, indicating a small site update rather than changes to the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedThe latest version updates the recruitment status to no longer looking for participants, indicating that enrollment has ceased. This change affects how prospective participants and researchers interpret the study's availability on the record page.SummaryDifference0.3%

- Check64 days agoChange DetectedA new page revision entry (v3.5.5) was added to the history, replacing the previous v3.5.4. This indicates a minor update to how the page renders or functions.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows a new site revision, changing from v3.5.3 to v3.5.4 to indicate a new build of the ClinicalTrials.gov interface. This is a metadata/UI version update rather than a change to the study data or content.SummaryDifference0.1%

Stay in the know with updates to Selonsertib in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib in Diabetic Kidney Disease Clinical Trial page.